Erik Teugels - Concepedia

Author

Erik Teugels

Also Known As

E Teugels, E. TEUGELS, E. Teugels, ERIK TEUGELS, Erik Teugels, Erik Teugels (88625), Rüdiger Klaes, Teugels, Erik, J De Grève

121

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Vrije Universiteit Brussel Universitair Ziekenhuis Brussel Ghent University Hospital Erasmus University College Brussels ZNA Middelheim Hospital

About

Erik Teugels is an author at Vrije Universiteit Brussel specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	1.2K
2	Health Sciences	3	3	105
3	Natural Sciences	3	3	124
4	Engineering	1	1	86
5	Public Health	1	1	16

Erik Teugels

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu Jacques De Grève, Erik Teugels, Caroline Geers, Lung Cancer	2012	277
miR-146a Inhibits Cell Growth, Cell Migration and Induces Apoptosis in Non-Small Cell Lung Cancer Cells Gang Chen, Ijeoma Adaku Umelo, Shasha Lv, PLoS ONE ImmunologyCell DeathCancer BiologyTumor BiologyOncology	2013	266
Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab Gang Chen, Peter Kronenberger, Erik Teugels, BMC Medicine	2012	126
Non-V600 BRAF mutations recurrently found in lung cancer predict sensitivity to the combination of Trametinib and Dabrafenib Amir Noeparast, Erik Teugels, Philippe Giron, Oncotarget Braf Kinase ActivityImpaired Braf KinasesPathologyCancer BiologyTumor Biology	2016	100
De novo Alu element insertions targeted to a sequence common to the BRCA1 and BRCA2 genes Erik Teugels, Sylvia De Brakeleer, Guido Goelen, Human Mutation	2005	99
Cancer predisposing missense and protein truncating<i>BARD1</i>mutations in non-<i>BRCA1</i>or<i>BRCA2</i>breast cancer families Sylvia De Brakeleer, Jacques De Grève, Remy Loris, Human Mutation EngineeringCancer PathologyGeneticsGenetic EpidemiologyPathology	2010	86
Phase II study of afatinib, an irreversible ErbB family blocker, in demographically and genotypically defined lung adenocarcinoma Jacques De Grève, Teresa Morán, Marie-Pascale Graas, Lung Cancer MedicineLung AdenocarcinomaPathologyPhase Ii StudyBronchial Neoplasm	2015	86
The <i>BRCA1</i> c. 5096G>A p.Arg1699Gln (R1699Q) intermediate risk variant: breast and ovarian cancer risk estimation and recommendations for clinical management from the ENIGMA consortium Setareh Moghadasi, Huong Meeks, Maaike P.G. Vreeswijk, Journal of Medical Genetics	2017	77
The αE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells Stefan Vermeulen, Friedel Nollet, Erik Teugels, Oncogene Tumor BiologyMedicineCancer Cell BiologyPathologyColorectal Cancer	1999	76
Genomic activation of the EGFR and HER2-neu genes in a significant proportion of invasive epithelial ovarian cancers Joanna Vermeij, Erik Teugels, Claire Bourgain, BMC Cancer	2008	68

Page 1